Longlife hericium bio 60 capsule
LongLife Hericium BIO 500 mg Descrizione Integratore alimentare a base di di Hericium titolato al 50% in polisaccaridi e al 20% in beta(1,3-1,6)-D-glucani, da agricoltura biologica. Adatto a vegani, DNA certificato, doping free. Ingredienti Hericium erinaceus sporoforo*; capsula di origine vegetale in idrossipropilmetilcellulosa. *Ingrediente biologico. Senza glutine. Caratteristiche nutrizionali Valori medi per 2 capsuleHericium erinaceus (Bull.) Pers* sporoforo polvere titolata 50% polisaccaridi totali 20% beta(1,3-1,6)-D-glucani1.000 mg500 mg200 mg Capsula di origine vegetale in idrossipropilmetilcellulosa Modalità d'uso Assumere 1 capsula due volte al giorno durante i pasti. Avvertenze Non eccedere la dose giornaliera raccomandata. Tenere fuori dalla portata dei bambini al di sotto dei 3 anni di età. Gli integratori non vanno intesi come sostituti di una dieta variata e vanno utilizzati seguendo uno stile di vita sano ed equilibrato. Conservazione Conservare in luogo fresco ed asciutto. Validità a confezionamento integro: 36 mesi. Formato Flacone contenente 60 capsule da 0,600 g. Peso netto: 36 g. Cod. 0419 Bibliografia -Phan CW et al., Hericium erinaceus (Bull.: Fr) Pers. cultivated under tropical conditions: isolation of hericenones and demonstration of NGF-mediated neurite outgrowth in PC12 cells via MEK/ERK and PI3K-Akt signaling pathways, Food Funct. 2014 Dec;5(12):3160-9. -Lee KF et al., Protective effects of Hericium erinaceus mycelium and its isolated erinacine A against ischemia-injury- induced neuronal cell death via the inhibition of iNOS/p38 MAPK and nitrotyrosine, Int J Mol Sci. 2014 Aug 27;15 (9):15073-89. -Jiang S et al., Medicinal properties of Hericium erinaceus and its potential to formulate novel mushroom-based pharmaceuticals, Appl Microbiol Biotechnol. 2014 Sep;98(18):7661-70. -Zhu Y et al., Preparation, characterization, and anti-Helicobacter pylori activity of Bi3+-Hericium erinaceus polysaccharide complex, Carbohydr Polym. 2014 Sep 22;110:231. -Xinyi Zan et al., Hericium erinaceus polysaccharide-protein HEG-5 inhibits SGC-7901 cell growth via cell cycle arrest and apoptosis, International Journal of Biological Macromolecules, 2015, 76, 242-253. Liu Z, et al., Systemic Screening of Strains of the Lion's Mane Medicinal Mushroom Hericium erinaceus(Higher Basidiomycetes) and Its Protective Effects on A-Triggered. -Neurotoxicity in PC12 Cells, Int J Med Mushrooms. 2015;17(3):219-29. -Zhang Yi et al., Protective Effect of Ethanol Extracts of Hericium erinaceus on Alloxan- Induced Diabetic Neuropathic Pain in Rats, Evidence-Based Complementary and Alternative Medicine Volume 2015, Article ID 595480, 5 pages. -Zan X et al., Hericium erinaceus polysaccharide-protein HEG-5 inhibits SGC-7901 cell growth via cell cycle arrest and apoptosis, Int J Biol Macromol. 2015 May;76:242-53. -Liu J et al., Anti-fatigue activities of polysaccharides extracted from Hericium erinaceus., Exp Ther Med. 2015 Feb;9 (2):483-487. -Wang K, et al., Erinacerins C-L, isoindolin-1-ones with-glucosidase inhibitory activity from cultures of the medicinal mushroom Hericium erinaceus, J Nat Prod. 2015 Jan 23;78(1):146-54. -Hou Y et al., Composition and antioxidant activity of water-soluble oligosaccharides from Hericium erinaceus, Mol Med Rep. 2015 May;11(5):3794-9. -Kobayashi H, et al., Effect of the replacement of aspartic acid/glutamic acid residues with asparagine/glutamine residues in RNase He1 from Hericium erinaceus on inhibition of human leukemia cell line proliferation., Biosci Biotechnol Biochem. 2015;79(2):211-7.
